Le Lézard
Classified in: Health
Subjects: NPT, CHI

More than 500 people are taking on the Leucan Shaved Head Challenge today


MONTREAL, May 26, 2019 /CNW Telbec/ - Today, more than 500 individuals from across Quebec are taking part in the provincial edition of the Leucan Shaved Head Challenge, presented by Proxim. This marks the 19th edition of the Challenge, a great wave of solidarity and hope for cancer-stricken children coping with hair loss due to chemotherapy.

More than 500 people are taking on the Leucan Shaved Head Challenge today (CNW Group/Leucan)

"Beyond the fundraiser and the shaving in itself, participants become, through their new look, ambassadors of the cause for several weeks to come. This is a tremendous commitment on their part," says Dominic Paquet, spokesperson of the Leucan Shaved Head Challenge for 8 consecutive years.

Among the 11 official shaving sites open today across the province, our largest venue is the Videotron Centre in Quebec City, with 115 participants registered. The money raised will enable Leucan to provide a range of support services to cancer-stricken children and their families, in addition to funding research in pediatric oncology.

Additional dates to take on the Challenge

People can still sign up for one of 30 additional Challenges scheduled in the upcoming months, or plan a Personalized Challenge and choose the date, time, place, and outreach of their event. For more information, please visit the Challenge's official website at tetesrasees.com.

Leucan wishes to highlight the generosity of Proxim, the presenting sponsor of the event for a 4th year; Mia for creating the Earrings of Hope for a 5th year and donating the sales proceeds to the Association; Subway for providing meals to volunteers at our shaving sites; and stand-up comedian Dominic Paquet, the Challenge's provincial spokesperson.

About the Challenge
The Leucan Shaved Head Challenge is a major fundraising campaign that engages the community in a wave of solidarity to provide families of cancer-stricken children with the services they need. It is also a gesture of support for children having to cope with a change in their appearance in the form of hair loss, a side-effect of chemotherapy.

About Leucan
For more than 40 years, Leucan has been committed to supporting cancer-stricken children and their families from the day of diagnosis and through every stage of cancer and its side-effects. As a loyal ally of hundreds of families and thousands of members across Quebec, the Association provides distinctive and tailored services delivered by a qualified team with a cutting-edge expertise. Leucan also funds clinical research and the Leucan Information Centre. With its nine offices, Leucan is available across the province.

About Proxim
Proxim was founded through the major grouping of independent pharmacists-owners. With more than 300 drugstores across Quebec, the pharmacists-owners affiliated with Proxim are leading health professionals in their respective communities. Their priority is to provide their patients with specialized and tailored care and support to promote better health.

 

SOURCE Leucan


These press releases may also interest you

at 07:15
Encoded Therapeutics Inc., a biotechnology company developing genetic medicines for severe central nervous system (CNS) disorders, today unveiled multiple pipeline programs ahead of the 27th ASGCT Annual meeting on May 7 - 11, 2024 in Baltimore, MD....

at 07:10
908 Devices Inc. , a pioneer of handheld and desktop devices for chemical and biochemical analysis, today announced it will report financial results for the first quarter 2024 before market open on Tuesday, April 30, 2024. Company management will...

at 07:10
Calidi Biotherapeutics Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, is pleased to invite investors to a webinar on April 24, 2024 at 4:15 p.m. ET. The exclusive event, hosted by RedChip...

at 07:10
ZYUS Life Sciences Corporation (the "Company") , a Canadian-based life sciences company focused on the development and commercialization of novel cannabinoid-based pharmaceutical drug candidates for pain management, announced today that the USPTO...

at 07:10
The National Kidney Foundation is applauding a move by Congress to increase access to care and improve outcomes for some patients on dialysis. The Improving Access to Home Dialysis Act (HR-8075) was introduced today in the U.S. House of...

at 07:05
hC Bioscience, a biopharmaceutical company developing a fundamentally novel approach to treating genetic diseases through tRNA-based protein editing, today announced preclinical data supporting its lead program in severe hemophilia A at the World...



News published on and distributed by: